ElendiLabs Logo
Back to Articles

Need Regulatory Help? Try Our Platform

Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.

Registration

April 18, 2025

Approximately 5 minutes

Medical Device Registration in Hong Kong: A Market and Regulatory Overview

From what we've observed, Hong Kong's healthcare sector is not just a market; it's a rapidly expanding opportunity for medical device companies, boasting substantial spending and continuous growth. The way medical devices are regulated here is mainly handled by the Medical Device Division (MDD), which oversees the Medical Device Administrative Control System (MDACS). While MDACS currently operates on a voluntary basis, to our understanding, it serves as a critical stepping stone for a future where these regulations might become mandatory.

According to our experience, specialized consulting services are invaluable for helping manufacturers successfully navigate the registration and approval process in Hong Kong, ensuring efficient and smooth market access.


What is the definition of a medical device in Hong Kong?

When we talk about "medical devices" in Hong Kong, what exactly does the Department of Health's Medical Device Division (MDD) consider to be one? According to their guidelines, a medical device is essentially any instrument, apparatus, machine, appliance, implant, software, material, or similar item. It's important that the manufacturer intends it to be used, either alone or with other things, for specific medical purposes in humans.

These purposes include:

  • Diagnosing, preventing, monitoring, treating, or easing diseases.
  • Diagnosing, monitoring, treating, easing, or compensating for an injury.
  • Investigating, replacing, modifying, or supporting the body's structure or how it works.
  • Supporting or sustaining life.
  • Controlling conception (like contraception).
  • Disinfecting other medical devices.
  • Providing medical information by examining samples from the human body (this is what IVDMs do!).

Crucially, a medical device does not achieve its main effect in or on the body through drugs, immune responses, or metabolism. However, it might be helped in its function by such means. So, it's pretty broad, covering everything from a simple bandage to complex diagnostic software!


Market Dynamics and Growth: What We're Seeing

Hong Kong's dedication to healthcare is clear from its robust spending, which reached a whopping HKD 199.9 billion during the fiscal year 2020/21. The medical equipment market, as we've witnessed, is continuously growing, with forecasts suggesting it could be worth US$1,006.00 million by 2028. From our perspective, this vibrant market, combined with an incredibly well-developed healthcare system, makes Hong Kong an attractive and strategic place for medical device manufacturers looking to grow their presence across Asia. This is particularly relevant for Hong Kong medical device market entry strategies.


The Role of the Medical Device Division (MDD): Our Key Partner

The MDD, as we know, stands as the central authority in charge of putting the MDACS into action and managing it day-to-day. What exactly are their main responsibilities? They include:

  • Setting up and sharing clear guidelines for listing various types of medical devices.
  • Keeping an eye on how importers, distributors, and local manufacturers are following the rules.
  • Making sure that all medical devices put on the market meet the established standards for safety and performance. The MDD is crucial for regulatory compliance Hong Kong.

Understanding Risk: Medical Device Classification

Hong Kong's MDACS uses a "risk-based" system to classify medical devices, which, to our understanding, mirrors international best practices. This system is incredibly important because it directly impacts how much regulatory scrutiny a device receives and how complex its registration process will be. Medical devices are generally put into these categories:

  • General Medical Devices: These are categorized into four tiers: Class I, II, III, and IV. What's the difference? Class I devices are the lowest risk (think bandages), while Class IV represents devices with the highest potential risk (like pacemakers).
  • In Vitro Diagnostic (IVD) Devices: These are similarly classified into four categories: Class A, B, C, and D. Class D signifies the highest risk for IVD devices (such as HIV diagnostic tests).

A core principle of MDACS, according to our experience, is that devices in higher risk classes face much tougher requirements when it comes to technical documents, conformity assessments (proving they meet standards), and keeping an eye on them after they're sold. This impacts medical device registration Hong Kong.


The Registration Process: Our Step-by-Step Guide

The process for getting a medical device registered in Hong Kong typically involves several key stages. We guide our clients through these steps, designed to ensure products meet all the necessary safety and performance criteria:

  1. Accurate Device Classification: This is the initial and truly critical step. It involves precisely figuring out the right risk classification for your medical device or IVD, following the MDACS rules. From our perspective, getting this right at the start sets the entire regulatory pathway.
  2. Appointment of a Local Responsible Person (LRP): If you're a manufacturer without a physical office in Hong Kong, designating a Local Responsible Person (LRP) is a must. Who is the LRP? The LRP acts as your official local representative, handling all formal communications between your company and the MDD. The LRP is also responsible for crucial compliance and post-market activities, making them vital for Hong Kong medical device import and distribution.
  3. Dossier Compilation and Submission: You need to prepare a comprehensive application package (what we often call a "dossier"). This includes all the required technical documents, such as the Summary Technical Documentation (STED), and clear proof that your device conforms to the Essential Principles of Safety and Performance. This complete package is then submitted to the MDD by your LRP.
  4. Regulatory Review and Follow-up: The MDD will conduct a thorough review of your submitted application. What happens during this phase? The MDD might send out queries or ask for additional information. Our experience tells us that prompt and accurate responses are crucial for an efficient review process and avoiding delays.
  5. Listing and Post-Market Vigilance: Once your review is successful and approved, your medical device will be given a unique listing number and added to the publicly accessible MDACS database. Is that the end of it? Not at all! Even after listing, ongoing compliance is paramount. This includes continuous post-market surveillance (keeping an eye on the device after it's sold), diligent adverse event reporting, initiating product recalls or field safety corrective actions when necessary, and telling the MDD about any significant changes to your listed device. These elements are key to medical device regulatory compliance Hong Kong.

By truly understanding and diligently following these regulatory requirements, manufacturers can effectively streamline their market entry into Hong Kong, ensuring product compliance and contributing to public health in this dynamic region.

Ask Anything

We'll follow up with you personally.

100% response rate • Reply within 7 business days

Your email will not be published. We'll only use it to notify you when we respond.

Questions & Answers (3)

A
Guest

我们生产高强度聚焦超声(HIFU)系统。在许多市场,这被认为是“美容”器械。MDACS是否将其归类为医疗器械?如果包装盒上没有“医疗声明”,我们是否可以避免进行II/III类注册,直接将其销售给美容诊所?

ElendiLabs

否。香港医疗器械管制局(MDD)对用于美容用途的“能量型仪器”有专门的监管。即使没有医疗声明,像HIFU、激光和冷冻溶脂系统这样的器械也受MDACS的监管,以确保安全。具体而言,如果器械的输出功率对使用者或患者构成风险,则必须进行登记。向诊所出售未列入清单的高风险能量设备将使您失去未来在卫生署/医院管理局的注册资格,并可能导致您的 LRP 根据 2026 年 CMPR 执行指引被列入黑名单。

A
Guest

我们目前持有二类诊断试剂盒的“B阶段”申请编号,去年我们凭借该编号向医院管理局销售了产品。随着2026年3月23日“C3阶段”截止日期的临近,我们的“申请编号”是否会自动转换为“备案编号”,还是我们需要重新提交申请?

ElendiLabs

不会自动转换。“B阶段”是过渡性采购许可。要符合“C阶段”的要求,您的设备必须拥有最终的香港医疗器械管理局备案编号。如果您的申请在2026年3月23日之前仍处于“待定”状态,您将无法参与医院管理局的新招标。您必须联系医疗器械指令处,加快审核流程,或立即提供补充技术资料,以确保在采购截止日期前获得备案。

A
Guest

我们目前通过香港的三家不同的分销商销售产品。之前提到LRP的必要性。如果我们指定最大的分销商作为LRP,其他两家分销商是否还能以同一LRP身份进口产品?或者LRP是否有权在海关阻止他们的货物入境?

ElendiLabs

根据(MDACS),LRP“拥有”该LRP的注册信息,但他们不一定是唯一的进口商。您可以在同一个LRP注册信息下授权多个“注册进口商”。但是,如果您的分销商是LRP,他们有权放弃该注册信息,或拒绝处理其他分销商的不良事件报告。为了保持商业中立,避免陷入“被挟持”的局面,我们建议您指定一家独立的LRP(例如ElendiLabs)来管理合规事宜,这样您就可以根据需要添加或移除任意数量的商业分销商。

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550